| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $55.9M | +7.5% |
| SG&A Expense | $24.2M | -3.2% |
| Operating Income | -$80.1M | -4.0% |
| Pre-tax Income | -$69.0M | +6.0% |
| Income Tax | $2K | +122.2% |
| Net Income | -$69.0M | +5.9% |
| EPS (Basic) | -$1.44 | +10.6% |
| EPS (Diluted) | -$1.44 | +10.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.7M | -65.2% |
| Short-term Investments | $165.4M | +24.6% |
| Current Assets | $207.4M | -16.0% |
| Total Assets | $252.2M | -6.7% |
| Current Liabilities | $14.0M | +29.5% |
| Total Liabilities | $26.5M | +9.0% |
| Stockholders' Equity | $225.7M | -8.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.7M | +12.7% |
| Capital Expenditures | $962K | -88.0% |
| Investing Cash Flow | -$50.5M | -3594.8% |
| Financing Cash Flow | $35.6M | +3613.7% |
| Free Cash Flow | -$56.6M | +21.1% |